Hypertonicity-induced binding of the transcription factor TonEBP͞ OREBP to its cognate DNA element, ORE͞TonE, is associated with increased transcription of several osmotically regulated genes. Previously, it was found that hypertonicity rapidly causes nuclear translocation and phosphorylation of TonEBP͞OREBP and, more slowly, increases TonEBP͞OREBP abundance. Also, the C terminus of TonEBP͞OREBP was found to contain a transactivation domain (TAD). We have now tested for tonicity dependence of the TAD activity of the 983 C-terminal amino acids of TonEBP͞OREBP. HepG2 cells were cotransfected with a reporter construct and one of several TAD expression vector constructs. The reporter construct contained GAL4 DNA binding elements, a minimal promoter, and the Photinus luciferase gene. TAD expression vectors generate chimeras comprised of the GAL4 DNA binding domain fused to (i) the 983 C-terminal amino acids of TonEBP͞OREBP, (ii) 17 glutamine residues, (iii) the TAD of c-Jun, or (iv) no TAD. All TAD-containing chimeras were functional at normal extracellular osmolality (300 mosmol͞kg), but the activity only of the chimera containing the 983 C-terminal amino acids of TonEBP͞OREBP varied with extracellular NaCl concentration, decreasing by >80% at 200 mosmol͞kg and increasing 8-fold at 500 mosmol͞kg. The chimera containing the 983 C-terminal amino acids of TonEBP͞OREBP was constitutively localized to the nucleus and showed tonicity-dependent posttranslational modification consistent with phosphorylation. The activity at 500 mosmol͞kg was reduced by herbimycin, a tyrosine kinase inhibitor and by 5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole, a protein kinase CK2 inhibitor. Thus, the 983 C-terminal amino acids of TonEBP͞OREBP contain a TAD that is regulated osmotically, apparently by tonicity-dependent phosphorylation.
O
smotic stress almost universally leads to the adaptive accumulation of intracellular organic osmolytes. This accumulation occurs through hypertonicity-induced transcription of genes whose promoters are controlled by the enhancer ORE͞ TonE (1, 2) . These genes include aldose reductase (AR), which mediates the synthesis of the osmolyte, sorbitol, and at least two transporters, the betaine͞␥-aminobutyric acid transporter (BGT1) and the sodium-myo-inositol cotransporter, which cause cellular accumulation of betaine and inositol, respectively. The cognate transcription factor of the ORE͞TonE enhancer is TonEBP͞OREBP (3, 4) .
Transcription factors are controlled at various levels by multiple factors and by combinatorial associations. Nuclear localization is effected by regulated association with nuclear importins and exportins as well as by regulated change in affinity or availability of anchor proteins (5) . DNA binding is controlled or modified by dimerization, posttranslational modification, and by cooperative interaction of associated proteins (6, 7) . Transactivation can be regulated also through DNA binding, association with heterologous transcription factors, and posttranslational modification (8) . In particular, single and multisite phosphorylation are key control signals at all levels of transcription factor regulation (9) including transactivation (6, 10) .
TonEBP͞OREBP, similar to many transcription factors, is controlled at multiple levels, only some of which are regulated osmotically. Hypertonicity rapidly causes nuclear translocation and phosphorylation of TonEBP͞OREBP (3, 4, 11) . More slowly, hypertonicity increases TonEBP͞OREBP abundance through induction of its mRNA and protein synthesis (3, 4) . The constitutive dimerization of TonEBP͞OREBP is required for DNA binding and transactivation but is independent of tonicity (12) . The role of phosphorylation has not been determined except that it is not required for DNA binding (11) .
The C terminus of TonEBP͞OREBP contains a transactivation domain (TAD; ref. 12) . Herein, we demonstrate that (i) activity of the TAD of TonEBP͞OREBP varies directly with extracellular NaCl concentration, (ii) high NaCl causes a posttranslational modification of the TAD that is consistent with increased phosphorylation, and (iii) kinase inhibitors reduce transactivation at high NaCl concentration.
Materials and Methods
Cell Culture and Media. HepG2 and HEK293 cells were grown in isotonic medium (300 mosmol͞kg) according to supplier instructions (American Type Culture Collection). At a point specific to a given experiment, fresh medium was substituted that had the same osmolality, was hypotonic [NaCl-free medium (Biofluids, Rockville, MD), adjusted to 200 mosmol͞kg by adding NaCl], or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl).
Six hours after altering NaCl concentration, nuclear proteins were extracted from HEK293 cells by using NE-PER (Pierce) and quantitated by using BCA protein assay (Pierce) according to manufacturer instructions. In some experiments, nuclear proteins were treated (20 units͞g of protein, 30 min, 30°C) with a dual specificity serine͞threonine͞tyrosine protein phosphatase (-PPase, New England Biolabs) according to supplier instructions.
Proteins were separated by SDS͞PAGE. Equal amounts of protein were loaded onto each lane of a 7.5% acrylamide͞ Tris⅐HCl gel; electrophoresis was carried out at 100 V. Proteins were transferred to an Immobilon P membrane (Millipore) at 110 mA for 1 h. Immunodetection was carried out by using an antibody specific to amino acids 1,513-1,531 of KIAA0827 (GenBank accession no. AB020634, Affinity BioReagents, Golden, CO).
Plasmids. ORE-Luc, containing bp Ϫ3,429 to ϩ27 of the rabbit AR gene upstream of the Photinus pyralis luciferase gene, has been described previously (ARLuc9 in ref. 13 ). The sequence Ϫ3,429 to ϩ27 includes the AR promoter and three ORE͞ TonEs in native gene context (GenBank accession no. U12317).
Human TonEBP͞OREBP cDNA clones AF089824 and KIAA0827 were gifts from H. Moo Kwon (Johns Hopkins University, Baltimore, MD) and Takahiro Nagase (Kazusa DNA Research Institute, Chiba, Japan), respectively.
The GAL4 reporter plasmid pFR-Luc (Stratagene) contains five tandem repeats of the yeast GAL4 binding site (upstream activating sequence) upstream of a minimal promoter (TATATA) and the P. pyralis luciferase gene. Plasmid pFA-CMV (Stratagene) contains a cytomegalovirus promoter upstream of the yeast GAL4 DNA binding domain (GAL4dbd, amino acids 1-147). GAL4dbd-TAD fusion proteins were generated by in-frame insertion into pFA-CMV as follows. The sequence coding for amino acids 548-1,531 of clone KIAA0827 was inserted to generate GAL4dbd-TonEBP͞OREBP. The sequence coding for the 17 monomeric polyglutamine stretch of clone KIAA0827 (amino acids 1,250-1,266) was inserted to generate GAL4dbd-polyQ. GAL4dbd-c-Jun contains the TAD sequence coding for amino acids 1-223 of c-Jun (pFA2-c-Jun, Stratagene). GAL4dbd contains no TAD (pFC2-dbd, Stratagene). pFC-MEKK (amino acids 380-672, Stratagene) phosphorylates pFA2-c-Jun.
Transfection and Luciferase Assays. HEK293 cells (passages 37-38) were grown in isotonic medium (300 mosmol͞kg) in 10-cm dishes. Cells were transfected with 6 g of GAL4dbd-TonEBP͞ OREBP using Effectene (Qiagen) according to manufacturer instructions.
HepG2 cells (passages 74-80) were grown in isotonic medium (300 mosmol͞kg) in 35-mm dishes. For GAL4dbd-TAD studies, cells were cotransfected with 1 g of pFR-Luc and 30 ng of either GAL4dbd-TonEBP͞OREBP or GAL4dbd-c-Jun (with or without 30 ng of pFC-MEKK) or 500 ng of GAL4dbd or GAL4dbd-polyQ using Lipofectamine 2000 (Life Technologies) according to manufacturer instructions. For ORE͞TonE reporter assays, cells were transfected with 5 g of ORE-Luc.
Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that had the same osmolality, was hypotonic (Biof luids NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Cells were exposed to inhibitors in isotonic medium beginning 1 h before altering NaCl concentration. Sixteen hours after altering NaCl concentration, cells were harvested by the addition of 150 l of passive lysis buffer (Dual luciferase reporter assay system, Promega). Cell lysates were analyzed for total protein (Bio-Rad protein assay kit). Photinus luciferase activity was determined on duplicate aliquots (Dual luciferase reporter assay system).
Transfection Data Analyses. Photinus luciferase activity was expressed in relative light units (RLUs) per g of total cell protein.
Immunocytochemistry. HepG2 cells were grown in isotonic medium in two-chamber plastic slides (Lab-Tek). When 80% confluent, cells were transfected with 5 g of the GAL4dbd-TonEBP͞OREBP construct by using Lipofectamine 2000 according to manufacturer instructions. Twenty-four hours after transfection, the medium was changed to 200, 300, or 500 mosmol͞kg. Six hours after the medium change, cells were fixed in 100% methanol at Ϫ20°C for 2 h and washed. Cells then were incubated with an antibody specific to amino acids 1,513-1,531 of KIAA0827 (Affinity Bioreagents). The secondary antibody was goat anti-rabbit IgG linked to Alexa 488 (Molecular Probes). Fluorescence microscopy was carried out with an inverted epifluorescence microscope (Nikon) coupled to a laser scanning unit (Odyssey, Noran Instruments, Middleton, WI). The fluorescence emission was excited with the 488-nm line from an argon ion laser and detected at wavelengths greater than 514 nm. The sample images were digitized at 8-bit resolution.
Real-Time PCR. PCR was performed on 8-and 80-ng cDNA samples per 20-l reaction in triplicate (n ϭ 1) by using Taqman universal PCR master mix (Applied Biosystems) according to manufacturer instructions with an ABI Prism 7900HT sequence detection system (Applied Biosystems). Primers directed against the human sequence of AR were 5Ј-ATCGCAGCCAAGCA-CAATAA-3Ј and 5Ј-AGCAATGCGTTCTGGTGTCA-3Ј; those for the human BGT1 were 5Ј-TGTTCAGCTCCTTCAC-CTCTGA-3Ј and 5Ј-GCAATGCTCTGTGTTCCAAAAG-3Ј. Fold difference in cDNA abundance (F) was calculated according to the formula F ϭ E (Ct1ϪCt2) . E (ϭ 1.98 Ϯ 0.056, n ϭ 18, mean Ϯ SEM) is the efficiency of the reaction determined by using AR and BGT1 gene-specific primers in reactions containing a 10-fold difference (8 and 80 ng) in cDNA template. Ct 1 and Ct 2 ϭ the number of cycles required to reach the threshold of amplicon abundance ( Fig. 7C ) for any two experimental conditions. Statistical Analysis. Data were compared by a one-way ANOVA followed by Dunnett's multiple comparison test for separation of significant means.
Results
To confirm that the C terminus of TonEBP͞OREBP contains a TAD (12), we cloned amino acids 548-1,531 into a GAL4 expression vector to generate the chimera GAL4dbd-TonEBP͞ OREBP. In this reporter system, generation of luciferase by a cotransfected reporter gene construct depends on the presence of a functional TAD fused to the GAL4dbd. The TAD may be regulated by factors that are endogenous or cotransfected. We examined the effect of different levels of NaCl in the medium on activity of TADs by measuring luciferase activity in HEPG2 cells. Our results confirm that amino acids 548-1,531 contain a TAD that is functional in isotonic medium (300 mosmol͞kg; Fig. 1 ).
The TAD of TonEBP͞OREBP is regulated osmotically. The activity of the TAD of TonEBP͞OREBP increased at least 8-fold in hypertonic medium (500 mosmol͞kg) and decreased greatly when the medium was made hypotonic (200 mosmol͞kg; Fig. 1 ). As controls in this experiment, the c-Jun and polyQ TADs (17 polyglutamine stretch in the C terminus of TonEBP͞ OREBP) each showed transactivation activity in isotonic medium, but neither chimera demonstrated osmotic dependence. That c-Jun TAD activity could be regulated was confirmed by marked increase (Ͼ50ϫ) when recombinant MEKK, its upstream activator, was cotransfected (data not shown). We assume that the response of the TonEBP͞OREBP TAD to NaCl concentration is caused by a change in tonicity and not to NaCl per se. Previous studies have demonstrated that ORE͞TonE-driven expression is similar in response to various agents capable of generating a tonic response such as NaCl or raffinose but not to permeating solutes such as urea (1) .
With an increase in tonicity, TonEBP͞OREBP translocates to the nucleus (3, 4) . Tonicity-induced nuclear localization is blocked by 1 M MG-132, a 26S proteasome inhibitor (14, 15) . To determine whether proteasomal degradation of a cofactor or inhibitor is involved in transactivation, we examined the effect of MG-132 on TAD function. We found that 1 M MG-132 had no significant effect on TAD activity regardless of tonicity (Fig. 2) . In real-time PCR experiments, HepG2 cells show 40-60% reduction of tonicity-induced AR and BGT1 mRNA expression with 1 M MG-132 (data not shown). Thus, as reported previously for other cells (14) , MG-132 reduces expression of genes whose transcription is regulated by ORE͞TonEs also in HepG2 cells. Therefore, although proteasomal degradation apparently is involved in tonicity-induced nuclear translocation of TonEBP͞ OREBP, we find no evidence that it has a role in tonicitydependent activation of the TonEBP͞OREBP TAD.
Although the TAD chimera lacks the TonEBP͞OREBP Nterminal putative nuclear localization sequence, it does contain the GAL4 nuclear localization sequence, which should lead to constitutive nuclear localization. To confirm this, HepG2 cells were transfected with the TAD construct, and TonEBP͞OREBP was visualized by immunofluorescence. We initially attempted to use antibodies specific for the GAL4dbd, but none of the available antibodies worked in our hands for detecting immunofluorescence of the TAD chimera in HepG2 cells. Therefore, we tested an antibody targeted to the C terminus of TonEBP͞ OREBP itself. A minority of cells displayed bright nuclear immunofluorescence (Fig. 3A) . These, presumably, were successfully transfected cells that were overexpressing the TAD chimera. In all these cells, the bright immunofluorescence was localized to the nucleus regardless of the osmolality. The majority of cells, which presumably were not transfected successfully, are invisible in Fig. 3A . However, they did appear when the brightness of the images was increased (Fig. 3B ). This dim immunofluorescence presumably represents the much lower level of native TonEBP͞OREBP. Its location depended on the osmolality as reported (refs. 3 and 4; Fig. 3B ). At 200 and 300 mosmol͞kg the native TonEBP͞OREBP is spread diffusely throughout the cell, but at 500 mosmol͞kg it is localized in the nucleus.
Posttranslational modification, particularly phosphorylation, commonly modulates the activity of transcription factors (9) . To determine whether phosphorylation of the TAD occurs at high NaCl concentration, we examined Western blots of nuclear protein extracts from HEK293 cells transfected with the GAL4dbd-TonEBP͞OREBP TAD construct. HEK293 cells can be transfected with greater efficiency than HepG2 cells but behave as do HepG2 cells in response to tonicity. HEK293 cells demonstrate tonicity dependence of TAD activity and ORE͞ TonE-driven gene expression (data not shown). The chimera containing the TAD of TonEBP͞OREBP from hypertonically treated HEK293 cells exhibited retarded electrophoretic mobility compared with that from cells treated with isotonic medium (Fig. 4) . This electrophoretic mobility difference was eliminated after phosphatase treatment, which is consistent with tonicityinduced phosphorylation of the ToneBP͞OREBP TAD (Fig. 4) .
Tyrosine and serine phosphorylation of TonEBP͞OREBP are known to increase with tonicity (11) , and the TAD contains both tyrosines and serines. Eleven of the serine residues are contained within putative CK2 sites. Because the TonEBP͞OREBP TAD undergoes tonicity-dependent phosphorylation, we examined the effect of herbimycin, a tyrosine kinase inhibitor, and DRB, a serine͞threonine protein kinase CK2 inhibitor, on TAD function (Fig. 5) . Both herbimycin and DRB significantly reduced activity of the TonEBP͞OREBP TAD at 500 mosmol͞kg (Fig.  5) . A more modest and statistically insignificant reduction occurred at 300 and 200 mosmol͞kg. We reasoned that such inhibition of transactivating activity might reduce transcriptional activity of native TonEBP͞OREBP. Therefore, we examined the effect of herbimycin or DRB on a reporter driven by ORE͞ TonEs, the cognate DNA element of TonEBP͞OREBP. When Fig. 1 . The TAD of TonEBP͞OREBP is regulated osmotically in contrast to control TAD chimeras that are not. HepG2 cells were cotransfected with pFR-Luc, a GAL4 upstream activating sequence reporter plasmid, and a GAL4dbd expression vector to generate either GAL4dbd alone or one of the following GAL4dbd-TAD chimeras: GAL4dbd-c-Jun, GAL4dbd-polyQ, or GAL4dbd-TonEBP͞OREBP. Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that had the same osmolality, was hypotonic (NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (500 mosmol͞kg by adding NaCl). Sixteen hours after altering the NaCl concentration cells were harvested, and Photinus luciferase activity was determined. The absolute activities of the GAL4dbd fusion proteins (RLUs per g of total cell protein) depend on which TAD is appended: None, 4 Ϯ 1; c-Jun, 629 Ϯ 251; polyQ, 11 Ϯ 3; TonEBP͞OREBP, 3,666 Ϯ 782. Mean Ϯ SEM; n Ն 3. Fig. 2 . TonEBP͞OREBP TAD activity is not affected significantly by the proteasome inhibitor MG-132. HepG2 cells were cotransfected with pFR-Luc, a GAL4 upstream activating sequence reporter plasmid, and an expression vector to generate a GAL4dbd-TonEBP͞OREBP TAD chimera. Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that had the same osmolality, was hypotonic (NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Cells were exposed to DMSO or MG-132 in isotonic medium beginning 1 h before altering NaCl. Sixteen hours after altering NaCl concentration cells were harvested, and Photinus luciferase activity was determined (RLUs per g of total cell protein). Values are normalized to cells at 300 mosmol͞kg treated with DMSO. Mean Ϯ SEM; n Ն 3.
HepG2 cells, transfected with ORELuc, were treated with herbimycin, luciferase activity was reduced significantly at all osmolalities (Fig. 6A) . We attribute the effects at 200 and 300 mosmol͞kg to partial activation of TonEBP͞OREBP at those osmolalities. Partial activation at 300 mosmol͞kg was demonstrated previously (15) . When treated with DRB, luciferase activity was reduced significantly at 500 mosmol͞kg (Fig. 6B) . DRB treatment resulted in statistically insignificant reduction at 200 and 300 mosmol͞kg (Fig. 6B) . We also tested whether herbimycin or DRB treatment affects the mRNA abundance of genes whose transcription is controlled by ORE͞TonEs. Both herbimycin and DRB reduced hypertonic induction of both AR and BGT1 genes as measured by quantitative Real-time PCR (Fig. 7 A and B) . A representative amplification plot is shown in Fig. 7C . Although DRB is known also to inhibit RNA polymerase II (16), the effects seen in the present study are not consistent with a general decrease in mRNA expression. BGT1 mRNA levels at 300 mosmol tend to increase rather than decrease with 10 M DRB treatment (Fig. 7B) . Additionally, 10 M DRB does not affect ␤-actin mRNA abundance at any tonicity as measured by real-time PCR (data not shown).
Discussion
Hypertonicity is known to increase the binding of TonEBP͞ OREBP to its cognate DNA elements, ORE͞TonEs, through increased nuclear abundance. This increase occurs through rapid translocation of existing TonEBP͞OREBP to the nucleus and also, more slowly, through increased mRNA transcription and protein synthesis (3, 4) . Additionally, hypertonicity results in an increase in phosphorylation of TonEBP͞OREBP (11) but the role of this posttranslational modification is unknown. In the present study, we show that transactivation activity of TonEBP͞ Fig. 3 . The GAL4dbd-TonEBP͞OREBP TAD is constitutively located in the nucleus. HepG2 cells were transfected with the GAL4dbd-TonEBP͞OREBP TAD construct. Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that had the same osmolality, was hypotonic (NaClfree medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). TonEBP͞OREBP was visualized by immunofluorescence using an antibody targeted to its C-terminal amino acids and a secondary antibody linked to Alexa 488. (A) A minority of cells displayed bright nuclear immunofluorescence. These, presumably, were successfully transfected cells that were overexpressing the TAD chimera. In all these cells the bright immunofluorescence was localized to the nucleus regardless of the osmolality. (B) The majority of cells, which presumably were not successfully transfected and are invisible in A, appear when the brightness of the images is increased. Brightness of cells at 300 and 500 mosmol͞kg was enhanced equally, whereas cells at 200 mosmol͞kg were enhanced further to be able to visualize immunofluorescence. This dim immunofluorescence presumably represents the much lower level of native TonEBP͞OREBP. Its location depends on the osmolality. At 200 and 300 mosmol͞kg the native TonEBP͞ OREBP is spread diffusely throughout the cell, but at 500 mosmol͞kg it is localized in the nucleus. Fig. 4 . The chimera containing the GAL4dbd-TonEBP͞OREBP TAD from hypertonically treated cells exhibits retarded electrophoretic mobility compared with that from cells treated with isotonic medium. The mobility difference is eliminated after phosphatase treatment. HEK293 cells were transfected with an expression vector to generate the GAL4dbd-TonEBP͞OREBP TAD chimera. Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that either had the same osmolality or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Six hours after altering NaCl concentration cells were harvested, and nuclear proteins were extracted. Nuclear proteins from cells at each osmolality were treated with a dualspecificity serine͞threonine͞tyrosine protein phosphatase (-PPase). Proteins were separated by SDS͞PAGE. Immunodetection was carried out by using an antibody targeted to the C-terminal amino acids of TonEBP͞OREBP.
Fig. 5.
TonEBP͞OREBP TAD activity at 500 mosmol͞kg is decreased by herbimycin, a tyrosine kinase inhibitor (A), and DRB, a serine͞threonine CK2 inhibitor (B). HepG2 cells were cotransfected with pFR-Luc, a GAL4 upstream activating sequence reporter plasmid, and an expression vector to generate a GAL4dbd-TonEBP͞OREBP TAD chimera. Twenty-four hours after transfection at 300 mosmol͞kg, fresh medium was substituted that had the same osmolality, was hypotonic (NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Cells were exposed to DMSO, herbimycin, or DRB in isotonic medium beginning 1 h before altering NaCl. Sixteen hours after altering NaCl concentration cells were harvested, and Photinus luciferase activity was determined (RLUs per g of total cell protein). Values are normalized to cells at 300 mosmol͞kg treated with DMSO. Mean Ϯ SEM; n Ն 3. * , P Յ 0.05.
OREBP varies directly with NaCl concentration and that this is correlated with apparent tonicity-dependent phosphorylation of the TAD of TonEBP͞OREBP. The increase in TonEBP͞ OREBP TAD activity at elevated NaCl concentrations is independent of tonicity-modulated nuclear translocation. Nuclear localization is necessary for transcription factor-driven gene expression, with translocation typically controlled through change in association with nuclear importins or exportins (YAP1 and NFAT) and͞or anchor proteins (NF-B and MAPK; ref. 5). Native TonEBP͞OREBP, under isotonic conditions, is both cytosolic and nuclear. With an increase in tonicity, TonEBP͞ OREBP translocates to the nucleus (3, 4). Tonicity-modulated nuclear localization is blocked by MG-132, a 26S proteasome inhibitor (14) . MG-132 also inhibits the tonicity-induced increase in mRNA abundance of three genes whose transcription is regulated by ORE͞TonEs, AR, BGT1, and the sodium-myoinositol cotransporter (ref. 14 and present study). As a result, a tonicity-dependent increase in nuclear TonEBP͞OREBP is proposed as the key event in driving ORE͞TonE-dependent genes (15) . Although nuclear localization of TonEBP͞OREBP is necessary, osmotic regulation of TAD function is independent of tonicity-driven nuclear localization. The TAD chimera lacks the TonEBP͞OREBP N-terminal putative nuclear localization sequence and, unlike native TonEBP͞OREBP, is constitutively located in the nucleus. Nuclear localization of the TonEBP͞ OREBP TAD chimera is due to the presence of the GAL4dbd.
TonEBP͞OREBP TAD activity apparently is independent of the proteasome. Proteasomal degradation may regulate transcription factor activity independently of nuclear translocation, e.g., precursor degradation may be required to generate a subunit or cofactor [NF-B (6)]. To examine the involvement of the proteasome in TonEBP͞OREBP transactivation, we tested The sequence Ϫ3,429 to ϩ27 includes the AR promoter and three ORE͞TonEs in native gene context. Twenty-four hours after transfection at 300 mosmol͞ kg, fresh medium was substituted that had the same osmolality, was hypotonic (NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Cells were exposed to DMSO, herbimycin, or DRB in isotonic medium beginning 1 h before altering NaCl. Sixteen hours after altering NaCl concentration cells were harvested, and Photinus luciferase activity was determined (RLUs per g of total cell protein). Values are normalized to cells at 300 mosmol͞kg treated with DMSO. Mean Ϯ SEM; n Ն 3. * , P Յ 0.05. Fig. 7 . ORE͞TonE-dependent AR (A) and BGT1 (B) gene expression is depressed at high extracellular NaCl concentration by herbimycin, a tyrosine kinase inhibitor, and DRB, a serine͞threonine CK2 inhibitor. HepG2 cells were grown at 300 mosmol͞kg. Fresh medium was substituted that had the same osmolality, was hypotonic (NaCl-free medium, adjusted to 200 mosmol͞kg by adding NaCl), or was hypertonic (adjusted to 500 mosmol͞kg by adding NaCl). Cells were exposed to DMSO, herbimycin, or DRB in isotonic medium beginning 1 h before altering NaCl concentration. Total RNA was isolated 16 h after altering NaCl concentration and reverse-transcribed. Real-time PCR was used to determine cDNA abundance. Mean Ϯ SEM; n Ն 3. * , P Յ 0.05. the same concentration of MG-132 known to inhibit ORE͞ TonE-driven gene expression (14) , but we found no significant effect regardless of tonicity. The effect of MG-132 on TonEBP͞ OREBP regulation, thus, may be limited to inhibition of tonicitydependent nuclear translocation of the protein. The mechanism could be similar to that of NF-B, the translocation of which to the nucleus depends on proteasome degradation of the inhibitor IB (5). Although nuclear localization of TonEBP͞OREBP may be blocked by an unknown cofactor analogous to IB, tonicitydependent transactivation evidently is independent of the proteasome.
The requirement for dimer formation in TonEBP͞OREBP transactivation (12) may be met by the GAL4dbd of the TAD chimera. The TonEBP͞OREBP TAD chimera used in the present study lacks the N-terminal dimerization domain, but because the GAL4 DNA binding domain acts as a dimer, any requirement for dimerization could be met by this system. Dimerization of native TonEBP͞OREBP is independent of tonicity (12) . Although dimerization is required for transactivation, apparently it is not responsible for increased transactivation at high extracellular NaCl concentrations.
The C terminus of TonEBP͞OREBP contains a TAD that is regulated osmotically. Similar to CREB and CREM, the C terminus of TonEBP͞OREBP contains two homopolymeric glutamine stretches (10) . Glutamine-rich domains are thought to act as surfaces for interaction with components of the basal transcription machinery such as cofactors for RNA polymerase II and thus are characteristic of TADs (10, (17) (18) (19) . We have shown that C-terminal amino acids (548-1,531) of TonEBP͞ OREBP contain a TAD that is functional in isotonic medium, confirming previous results with a similar construct (12) . Additionally, we demonstrate that the TAD of TonEBP͞OREBP is regulated osmotically in contrast to control TAD chimeras that are not. These results evidence a new level of tonicity dependence in the regulation of TonEBP͞OREBP.
The TonEBP͞OREBP TAD apparently becomes phosphorylated, at high NaCl concentrations, coincident with increased transactivation activity. Phosphorylation can potentiate transactivation in several ways. Phosphorylation can regulate transactivation (CREB) by recruiting coactivator proteins that contact the general transcriptional machinery (10) . Phosphorylation also may be required for maximal transcriptional activity (STAT1 and NF-B) or for the formation of stable homodimer-DNA complexes (STAT3␣; refs. 6 and 8). Tyrosine and serine phosphorylation of native TonEBP͞OREBP increase with tonicity (11); the specific residues have not been identified, and the role of tonicity-dependent phosphorylation is unknown other than that it is unnecessary for DNA binding (11) . Here we provide evidence that the TonEBP͞OREBP TAD chimera is phosphorylated at high extracellular NaCl concentrations. Additionally, we show that herbimycin, a tyrosine kinase inhibitor, and DRB, a serine͞threonine CK2 inhibitor, reduce TonEBP͞OREBP activity in several independent ways. Both herbimycin and DRB reduce the activity of the ToneBP͞OREBP TAD chimera at 500 mosmol͞kg, which may indicate that a phosphorylation event is necessary for maximal transcription activity. In support of this theory, herbimycin and DRB each decrease tonicity-dependent activity of native TonEBP͞OREBP. This decreased activity was shown in two ways. Expression of an ORE͞TonE-driven reporter was reduced at 500 mosmol͞kg by DRB and at all tonicities by herbimycin. ORE͞TonE-dependent AR and BGT1 gene expression was depressed at high extracellular NaCl concentrations by both inhibitors. The C-terminal amino acids (548-1,531) of TonEBP͞OREBP contain tyrosine residues as well as serine residues within consensus sites for CK2 phosphorylation. Thus, maximal activation of the TonEBP͞OREBP TAD may involve tonicity-dependent phosphorylation.
Currently, we can summarize the regulation of TonEBP͞ OREBP as follows. Hypertonicity leads to an increase in DNA binding of TonEBP͞OREBP to its cognate DNA elements through increased abundance of the protein in the nucleus. TonEBP͞OREBP abundance increases in the nucleus through tonicity-dependent translocation from the cytosol of existing protein and, in the longer term, through increased protein synthesis and transcription of its mRNA (3, 4) . An N-terminal DNA binding domain has been identified as having a putative nuclear localization sequence (4). Nuclear localization may be inhibited by a cytosolic cofactor that is degraded in the proteasome in a fashion analogous to IB inhibition of NF-B (14) . An N-terminal dimerization domain also has been identified (12) . Dimerization is required for DNA binding, but TonEBP͞ OREBP forms a dimer constitutively, i.e., dimer formation is independent of tonicity (12) . Dimerization is required also for transactivation (12) . The C terminus of TonEBP͞OREBP contains a TAD that is regulated osmotically (this study). Hypertonicity results in increased phosphorylation of TonEBP͞ OREBP on tyrosine and serine residues (11) . Whereas DNA binding is independent of tonicity-induced phosphorylation (11) , maximal transactivation may involve tonicity-dependent phosphorylation of the TAD (this study).
